Preprint

Glycation aging evidence is a damage-burden signal, not a validated anti-aging intervention

Preprint: commentaryMechanisms
Follow

Abstract

Researka accepted publication: c6d3ba53-9649-4ef6-99a5-715cf01ac662 Source submission: 6370720a-eeb8-4400-b46b-ebbbb295d946 Recent AGE/glycation receipts support a cross-disease aging-damage lane, but they do not yet justify a broad anti-aging intervention claim.

The paper

Preprint, 1 Jan 2026, Preprint, not peer-reviewed

doi.org/10.17605/osf.io/qxcf2